A potential therapeutic strategy for chronic lymphocytic leukemia by combining Idelalisib and GS-9973, a novel spleen tyrosine kinase (Syk) inhibitor

Name: Work Video:
Duration: 3 min 30 s
Russell T. Burke; Sarah Meadows; Marc Loriaux; Kevin Currie; Scott A. Mitchell; Patrícia Maciejewski; Astrid Clarke; Julie DiPaolo; Brian J. Druker; Brian J. Lannutti; Stephen E. Spurgeon
{'id': 'https://openalex.org/W1863976964', 'doi': 'https://doi.org/10.18632/oncotarget.1484', 'title': 'A potential therapeutic strategy for chronic lymphocytic leukemia by combining Idelalisib and GS-9973, a novel spleen tyrosine kinase (Syk) inhibitor', 'display_name': 'A potential therapeutic strategy for chronic lymphocytic leukemia by combining Idelalisib and GS-9973, a novel spleen tyrosine kinase (Syk) inhibitor', 'publication_year': 2014, 'publication_date': '2014-02-28', 'ids': {'openalex': 'https://openalex.org/W1863976964', 'doi': 'https://doi.org/10.18632/oncotarget.1484', 'mag': '1863976964', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/24659719', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/4011593'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.18632/oncotarget.1484', 'pdf_url': 'https://www.oncotarget.com/article/1484/pdf/', 'source': {'id': 'https://openalex.org/S126644158', 'display_name': 'Oncotarget', 'issn_l': '1949-2553', 'issn': ['1949-2553'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316297', 'host_organization_name': 'Impact Journals LLC', 'host_organization_lineage': ['https://openalex.org/P4310316297'], 'host_organization_lineage_names': ['Impact Journals LLC'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'gold', 'oa_url': 'https://www.oncotarget.com/article/1484/pdf/', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5004143365', 'display_name': 'Russell T. Burke', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I165690674', 'display_name': 'Oregon Health & Science University', 'ror': 'https://ror.org/009avj582', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I165690674']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Russell T Burke', 'raw_affiliation_strings': ['Knight Cancer Institute, Oregon Health and Science University Portland OR'], 'affiliations': [{'raw_affiliation_string': 'Knight Cancer Institute, Oregon Health and Science University Portland OR', 'institution_ids': ['https://openalex.org/I165690674']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5003025066', 'display_name': 'Sarah Meadows', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210140816', 'display_name': 'Gilead Sciences (United States)', 'ror': 'https://ror.org/056546b03', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Sarah Meadows', 'raw_affiliation_strings': ['Gilead Sciences Inc, Seattle, WA'], 'affiliations': [{'raw_affiliation_string': 'Gilead Sciences Inc, Seattle, WA', 'institution_ids': ['https://openalex.org/I4210140816']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5054155535', 'display_name': 'Marc Loriaux', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I165690674', 'display_name': 'Oregon Health & Science University', 'ror': 'https://ror.org/009avj582', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I165690674']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Marc M Loriaux', 'raw_affiliation_strings': ['Division of Pathology, Oregon Health & Science University, Portland, OR', 'Knight Cancer Institute, Oregon Health & Science University, Portland, OR'], 'affiliations': [{'raw_affiliation_string': 'Knight Cancer Institute, Oregon Health & Science University, Portland, OR', 'institution_ids': ['https://openalex.org/I165690674']}, {'raw_affiliation_string': 'Division of Pathology, Oregon Health & Science University, Portland, OR', 'institution_ids': ['https://openalex.org/I165690674']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5079048350', 'display_name': 'Kevin Currie', 'orcid': 'https://orcid.org/0000-0002-1716-9799'}, 'institutions': [{'id': 'https://openalex.org/I4210140816', 'display_name': 'Gilead Sciences (United States)', 'ror': 'https://ror.org/056546b03', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kevin S. Currie', 'raw_affiliation_strings': ['Gilead Sciences Inc, Branford, CT'], 'affiliations': [{'raw_affiliation_string': 'Gilead Sciences Inc, Branford, CT', 'institution_ids': ['https://openalex.org/I4210140816']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5050840284', 'display_name': 'Scott A. Mitchell', 'orcid': 'https://orcid.org/0000-0003-3710-4500'}, 'institutions': [{'id': 'https://openalex.org/I4210140816', 'display_name': 'Gilead Sciences (United States)', 'ror': 'https://ror.org/056546b03', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Scott A. Mitchell', 'raw_affiliation_strings': ['Gilead Sciences Inc, Branford, CT'], 'affiliations': [{'raw_affiliation_string': 'Gilead Sciences Inc, Branford, CT', 'institution_ids': ['https://openalex.org/I4210140816']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5022111486', 'display_name': 'Patrícia Maciejewski', 'orcid': 'https://orcid.org/0000-0003-0760-0861'}, 'institutions': [{'id': 'https://openalex.org/I4210140816', 'display_name': 'Gilead Sciences (United States)', 'ror': 'https://ror.org/056546b03', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Patricia Maciejewski', 'raw_affiliation_strings': ['Gilead Sciences Inc, Branford, CT'], 'affiliations': [{'raw_affiliation_string': 'Gilead Sciences Inc, Branford, CT', 'institution_ids': ['https://openalex.org/I4210140816']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110584254', 'display_name': 'Astrid Clarke', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210140816', 'display_name': 'Gilead Sciences (United States)', 'ror': 'https://ror.org/056546b03', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Astrid S. Clarke', 'raw_affiliation_strings': ['Gilead Sciences Inc, Branford, CT'], 'affiliations': [{'raw_affiliation_string': 'Gilead Sciences Inc, Branford, CT', 'institution_ids': ['https://openalex.org/I4210140816']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5070391567', 'display_name': 'Julie DiPaolo', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210140816', 'display_name': 'Gilead Sciences (United States)', 'ror': 'https://ror.org/056546b03', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Julie A. Dipaolo', 'raw_affiliation_strings': ['Gilead Sciences Inc, Branford, CT'], 'affiliations': [{'raw_affiliation_string': 'Gilead Sciences Inc, Branford, CT', 'institution_ids': ['https://openalex.org/I4210140816']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5033023115', 'display_name': 'Brian J. Druker', 'orcid': 'https://orcid.org/0000-0001-8331-8206'}, 'institutions': [{'id': 'https://openalex.org/I1344073410', 'display_name': 'Howard Hughes Medical Institute', 'ror': 'https://ror.org/006w34k90', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1344073410']}, {'id': 'https://openalex.org/I165690674', 'display_name': 'Oregon Health & Science University', 'ror': 'https://ror.org/009avj582', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I165690674']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Brian J. Druker', 'raw_affiliation_strings': ['Howard Hughes Medical Institute, Bethesda, MD', 'Knight Cancer Institute, Oregon Health & Science University, Portland, OR'], 'affiliations': [{'raw_affiliation_string': 'Howard Hughes Medical Institute, Bethesda, MD', 'institution_ids': ['https://openalex.org/I1344073410']}, {'raw_affiliation_string': 'Knight Cancer Institute, Oregon Health & Science University, Portland, OR', 'institution_ids': ['https://openalex.org/I165690674']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5053545098', 'display_name': 'Brian J. Lannutti', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210140816', 'display_name': 'Gilead Sciences (United States)', 'ror': 'https://ror.org/056546b03', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Brian J. Lannutti', 'raw_affiliation_strings': ['Gilead Sciences Inc, Seattle, WA'], 'affiliations': [{'raw_affiliation_string': 'Gilead Sciences Inc, Seattle, WA', 'institution_ids': ['https://openalex.org/I4210140816']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5003766253', 'display_name': 'Stephen E. Spurgeon', 'orcid': 'https://orcid.org/0000-0001-9962-438X'}, 'institutions': [{'id': 'https://openalex.org/I165690674', 'display_name': 'Oregon Health & Science University', 'ror': 'https://ror.org/009avj582', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I165690674']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Stephen E. Spurgeon', 'raw_affiliation_strings': ['Division of Hematology and Medical Oncology, Oregon Health & Science University', 'Knight Cancer Institute, Oregon Health & Science University, Portland, OR'], 'affiliations': [{'raw_affiliation_string': 'Knight Cancer Institute, Oregon Health & Science University, Portland, OR', 'institution_ids': ['https://openalex.org/I165690674']}, {'raw_affiliation_string': 'Division of Hematology and Medical Oncology, Oregon Health & Science University', 'institution_ids': ['https://openalex.org/I165690674']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 3, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 7.243, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 66, 'citation_normalized_percentile': {'value': 0.999851, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 97, 'max': 98}, 'biblio': {'volume': '5', 'issue': '4', 'first_page': '908', 'last_page': '915'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11215', 'display_name': 'Chronic Myeloid Leukemia Treatments', 'score': 0.9982, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11016', 'display_name': 'Monoclonal and Polyclonal Antibodies Research', 'score': 0.992, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/idelalisib', 'display_name': 'Idelalisib', 'score': 0.95737004}], 'concepts': [{'id': 'https://openalex.org/C2779260929', 'wikidata': 'https://www.wikidata.org/wiki/Q5908266', 'display_name': 'Idelalisib', 'level': 5, 'score': 0.95737004}, {'id': 'https://openalex.org/C35174551', 'wikidata': 'https://www.wikidata.org/wiki/Q7660502', 'display_name': 'Syk', 'level': 4, 'score': 0.9184679}, {'id': 'https://openalex.org/C2777938653', 'wikidata': 'https://www.wikidata.org/wiki/Q1088156', 'display_name': 'Chronic lymphocytic leukemia', 'level': 3, 'score': 0.64195716}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.63110197}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.6026158}, {'id': 'https://openalex.org/C90059517', 'wikidata': 'https://www.wikidata.org/wiki/Q423572', 'display_name': "Bruton's tyrosine kinase", 'level': 4, 'score': 0.5799167}, {'id': 'https://openalex.org/C42362537', 'wikidata': 'https://www.wikidata.org/wiki/Q87099740', 'display_name': 'Tyrosine kinase', 'level': 3, 'score': 0.5643496}, {'id': 'https://openalex.org/C2779878957', 'wikidata': 'https://www.wikidata.org/wiki/Q5984881', 'display_name': 'Ibrutinib', 'level': 4, 'score': 0.4801021}, {'id': 'https://openalex.org/C2778820342', 'wikidata': 'https://www.wikidata.org/wiki/Q906415', 'display_name': 'Tyrosine-kinase inhibitor', 'level': 3, 'score': 0.477222}, {'id': 'https://openalex.org/C2778461978', 'wikidata': 'https://www.wikidata.org/wiki/Q29496', 'display_name': 'Leukemia', 'level': 2, 'score': 0.473027}, {'id': 'https://openalex.org/C2780931953', 'wikidata': 'https://www.wikidata.org/wiki/Q9371', 'display_name': 'Spleen', 'level': 2, 'score': 0.45170203}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.42631412}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.30367213}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.23321247}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.19938394}], 'mesh': [{'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D047908', 'descriptor_name': 'Intracellular Signaling Peptides and Proteins', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D015451', 'descriptor_name': 'Leukemia, Lymphocytic, Chronic, B-Cell', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D011505', 'descriptor_name': 'Protein-Tyrosine Kinases', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D017209', 'descriptor_name': 'Apoptosis', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D004357', 'descriptor_name': 'Drug Synergism', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007191', 'descriptor_name': 'Indazoles', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D010766', 'descriptor_name': 'Phosphorylation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011687', 'descriptor_name': 'Purines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D052999', 'descriptor_name': 'Quinazolinones', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D015398', 'descriptor_name': 'Signal Transduction', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D000072377', 'descriptor_name': 'Syk Kinase', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.18632/oncotarget.1484', 'pdf_url': 'https://www.oncotarget.com/article/1484/pdf/', 'source': {'id': 'https://openalex.org/S126644158', 'display_name': 'Oncotarget', 'issn_l': '1949-2553', 'issn': ['1949-2553'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316297', 'host_organization_name': 'Impact Journals LLC', 'host_organization_lineage': ['https://openalex.org/P4310316297'], 'host_organization_lineage_names': ['Impact Journals LLC'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc4011593', 'pdf_url': 'https://europepmc.org/articles/pmc4011593?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011593', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/24659719', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.18632/oncotarget.1484', 'pdf_url': 'https://www.oncotarget.com/article/1484/pdf/', 'source': {'id': 'https://openalex.org/S126644158', 'display_name': 'Oncotarget', 'issn_l': '1949-2553', 'issn': ['1949-2553'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316297', 'host_organization_name': 'Impact Journals LLC', 'host_organization_lineage': ['https://openalex.org/P4310316297'], 'host_organization_lineage_names': ['Impact Journals LLC'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'No poverty', 'score': 0.42, 'id': 'https://metadata.un.org/sdg/1'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 27, 'referenced_works': ['https://openalex.org/W1531083786', 'https://openalex.org/W1886402127', 'https://openalex.org/W1971436806', 'https://openalex.org/W1972593274', 'https://openalex.org/W1976058906', 'https://openalex.org/W1983395516', 'https://openalex.org/W1989593746', 'https://openalex.org/W1993986769', 'https://openalex.org/W2019655196', 'https://openalex.org/W2022978203', 'https://openalex.org/W2025786205', 'https://openalex.org/W2027971058', 'https://openalex.org/W2035916624', 'https://openalex.org/W2040604274', 'https://openalex.org/W2041122217', 'https://openalex.org/W2071549499', 'https://openalex.org/W2075875145', 'https://openalex.org/W2077945404', 'https://openalex.org/W2120150208', 'https://openalex.org/W2143375298', 'https://openalex.org/W2151672555', 'https://openalex.org/W2154992334', 'https://openalex.org/W2160892014', 'https://openalex.org/W2169269721', 'https://openalex.org/W2585992097', 'https://openalex.org/W4231004015', 'https://openalex.org/W4312734170'], 'related_works': ['https://openalex.org/W4252379246', 'https://openalex.org/W3083764575', 'https://openalex.org/W2990290302', 'https://openalex.org/W2955099322', 'https://openalex.org/W2614001962', 'https://openalex.org/W2557815702', 'https://openalex.org/W2192521460', 'https://openalex.org/W2168006562', 'https://openalex.org/W2117123429', 'https://openalex.org/W1830209188'], 'abstract_inverted_index': {'//': [0, 111], 'Russell': [1], 'T': [2], 'Burke': [3], '1': [4, 53], ',': [5, 9, 14, 19, 24, 28, 33, 38, 43], 'Sarah': [6], 'Meadows': [7], '2': [8, 47, 64], 'Marc': [10], 'M': [11], 'Loriaux': [12], '1,4': [13], 'Kevin': [15], 'S.': [16, 30], 'Currie': [17], '3': [18, 23, 27, 32, 37, 70], 'Scott': [20], 'A.': [21, 35], 'Mitchell': [22], 'Patricia': [25], 'Maciejewski': [26], 'Astrid': [29], 'Clarke': [31], 'Julie': [34], 'Dipaolo': [36], 'Brian': [39, 44], 'J.': [40, 45], 'Druker': [41], '1,5': [42], 'Lannutti': [46], ',and': [48], 'Stephen': [49, 107], 'E.': [50, 108], 'Spurgeon': [51], '1,6': [52], 'Knight': [54], 'Cancer': [55], 'Institute,': [56, 91], 'Oregon': [57, 80, 101], 'Health': [58, 81, 102], '&': [59, 82, 103], 'Science': [60, 83, 104], 'University,': [61, 84], 'Portland,': [62, 85], 'OR.': [63], 'Gilead': [65, 71], 'Sciences': [66, 72], 'Inc,': [67, 73], 'Seattle,': [68], 'WA': [69], 'Branford,': [74], 'CT': [75], '4': [76], 'Division': [77, 95], 'of': [78, 96, 162, 195, 213, 227, 284], 'Pathology,': [79], 'OR': [86], '5': [87], 'Howard': [88], 'Hughes': [89], 'Medical': [90, 99], 'Bethesda,': [92], 'MD': [93], '6': [94], 'Hematology': [97], 'and': [98, 155, 166, 197, 215, 233, 242, 252, 258, 265, 278], 'Oncology,': [100], 'University': [105], 'Correspondence:': [106], 'Spurgeon,': [109], 'email:': [110], 'Keywords': [112], ':': [113, 127, 132, 137], 'Chronic': [114, 245], 'Lymphocytic': [115, 246], 'Leukemia,': [116], 'B-cell': [117, 145, 179], 'receptor,': [118], 'signaling': [119, 148, 180, 208, 269], 'pathways,': [120, 181], 'spleen': [121, 167], 'tyrosine': [122, 168], 'kinase,': [123], 'PI3': [124, 163], 'kinase': [125, 164, 169], 'Received': [126], 'October': [128, 133, 138], '9,': [129], '2013': [130, 135, 140], 'Accepted': [131], '28,': [134], 'Published': [136], '30,': [139], 'Abstract': [141], 'Agents': [142], 'that': [143], 'target': [144], 'receptor': [146], '(BCR)': [147], 'in': [149, 199, 238, 259, 274], 'lymphoid': [150], 'malignancies': [151], 'including': [152, 273], 'idelalisib': [153, 182, 228], '(GS-1101)': [154], 'fostamatinib': [156], 'which': [157], 'inhibit': [158], 'the': [159, 206, 224, 231], 'delta': [160], 'isoform': [161], '(PI3Kd)': [165], '(Syk)': [170], 'respectively': [171], 'have': [172], 'shown': [173], 'significant': [174], 'clinical': [175, 290], 'activity.': [176, 291], 'By': [177], 'disrupting': [178], 'treatment': [183], 'has': [184, 217], 'been': [185, 220], 'associated': [186], 'with': [187, 210, 230], 'a': [188], 'dramatic': [189], 'lymph': [190], 'node': [191], 'response,': [192], 'but': [193], 'eradication': [194], 'disease': [196, 202], 'relapse': [198], 'high': [200], 'risk': [201, 280], 'remain': [203], 'challenges.': [204], 'Targeting': [205], 'BCR': [207], 'pathway': [209], 'simultaneous': [211], 'inhibition': [212, 254, 264], 'PI3Kd': [214, 251], 'Syk': [216, 235, 253], 'not': [218], 'yet': [219], 'reported.': [221], 'We': [222], 'evaluated': [223], 'pre-clinical': [225], 'activity': [226], 'combined': [229], 'novel': [232], 'selective': [234], 'inhibitor': [236], 'GS-9973': [237], 'primary': [239], 'peripheral': [240], 'blood': [241], 'bone': [243, 275], 'marrow': [244, 276], 'Leukemia': [247], '(CLL)': [248], 'samples.': [249, 281], 'Both': [250], 'reduced': [255], 'CLL': [256], 'survival': [257], 'combination': [260], 'induced': [261], 'synergistic': [262], 'growth': [263], 'further': [266], 'disrupted': [267], 'chemokine': [268], 'at': [270], 'nanomolar': [271], 'concentrations': [272], 'derived': [277], 'poor': [279], 'Simultaneous': [282], 'targeting': [283], 'these': [285], 'kinases': [286], 'may': [287], 'significantly': [288], 'increase': [289]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1863976964', 'counts_by_year': [{'year': 2024, 'cited_by_count': 2}, {'year': 2023, 'cited_by_count': 2}, {'year': 2022, 'cited_by_count': 3}, {'year': 2021, 'cited_by_count': 2}, {'year': 2020, 'cited_by_count': 3}, {'year': 2019, 'cited_by_count': 6}, {'year': 2018, 'cited_by_count': 6}, {'year': 2017, 'cited_by_count': 6}, {'year': 2016, 'cited_by_count': 12}, {'year': 2015, 'cited_by_count': 11}, {'year': 2014, 'cited_by_count': 13}], 'updated_date': '2024-12-10T23:48:47.254091', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
